The move follows strong industry data pointing to robust cruise demand and pricing trends holding firm through the second ...

Chris Senyek, Wolfe Research chief investment strategist, joins CNBC's 'Squawk on the Street' to discuss market outlooks, ...

Former deputy Treasury Secretary Roger Altman said he did not think Jerome Powell would agree to leave if the president asked ...

Stocks rebounded on Wednesday after President Donald Trump denied reports that he was close to ousting Powell as chairman of ...

Johnson & Johnson (NYSE:JNJ) is one of Goldman Sachs’ top healthcare stock picks. On July 10, analysts at Wolfe Research ...

Fintel reports that on July 15, 2025, Wolfe Research downgraded their outlook for Realty Income (NYSE:O) from Outperform to ...

Overall, Wolfe favors a mix of growth and value as the second half of 2025 begins. Related articles Wolfe Research refreshes high-conviction ideas heading into H2 ...

The research firm reiterated the company’s solid position amid the “TTR craze” while also echoing its commercial execution strategy. Wolfe Research Initiates Coverage of BridgeBio Pharma ...

Investing.com -- Wolfe Research upgraded the M&A Independent sector to Market Weight from Underweight in a note Wednesday, citing a combination of stock underperformance and early signs of ...

Fintel reports that on May 13, 2025, Wolfe Research upgraded their outlook for Insulet (BMV:PODD) from Peer Perform to Outperform.

Fastenal (NASDAQ:FAST) on Thursday was upgraded to Peer Perform from a previous investment rating of Underperform by analysts at Wolfe Research. They said the industrial distributor appears well ...

Wolfe Research released a report discussing key investment themes for 2025, highlighting a stronger U.S. dollar and predicting a decline in long-term interest rates. The firm attributed the rise ...